HB TempCon has recently accomplished another seamless cross-border transportation mission for temperature-sensitive pharmaceuticals. Loaded with core medications from a multinational pharmaceutical enterprise, the company’s self-developed RKN containers departed from Incheon International Airport (Seoul, South Korea) and safely arrived at Soekarno-Hatta International Airport (Jakarta, Indonesia). Throughout the journey, the pharmaceuticals were maintained within the critical 2-8℃ range, ensuring full safety and stable quality—fully demonstrating HB TempCon’s professional prowess in the biomedical cold chain logistics sector. For this temperature-sensitive shipment, HB TempCon’s South Korean team delivered end-to-end customized services. From temperature-controlled container deployment and cargo loading to final delivery at the destination port, every process strictly adhered to the client’s high standards. With comprehensive, full-linkage guarantees, the company effectively supported the pharmaceutical enterprise in expanding its supply chain layout in the Southeast Asian market. To date, HB TempCon’s temperature controlled containers have served dozens of domestic and international pharmaceutical companies, accumulating extensive practical experience in cross-border biomedical transportation scenarios. The successful completion of this Seoul-Jakarta shipment further consolidates the company’s competitive edge in the Asia-Pacific biomedical cold chain logistics market. Moving forward, HB TempCon will continue to leverage its independent core technologies to provide safer, more efficient, and compliant cross-border transportation solutions for the global biomedical industry.